Researchers from Tel Aviv University and the Israel Institute for Biological Research in Ness Ziona have used the platform ...

The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections.

Multidisciplinary AI- and physics-driven modeling of the viral fusion process has enabled the discovery of an orally available drug inhibiting infection with multiple coronaviruses.

A study published in mBio details the vulnerability of coronaviruses to inhibitors of a small protein domain called Mac1, or the "macrodomain," found in all coronaviruses such as SARS-CoV-2 and ...

An unlikely hero has emerged in the fight against an "absolutely terrifying" virus which has again reared its head in Australia.

Recruitment initiated into the Phase 2 opaganib plus darolutamide study in patients with advanced prostate cancer, sponsored ...

South Korea–based biotech firm LUCA AICELL has developed LUCA V-Defense Nasal Spray, a drug-free nasal spray designed to form a protective barrier on the nasal lining—offering a modern solution in the ...

Novel research presented today at the 41st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE ...

Instead of extracting T-cells and engineering them in a lab, researchers have delivered mRNA directly into circulating immune ...